Ranbaxy acquires dermatological and lifestyle product range of Ochoa Labs


GURGAON, India Indian drug maker Ranbaxy announced Thursday that it had acquired the trademarks, marketing rights and product dossiers for the entire dermatological and lifestyle product range of New Delhi-based Ochoa Labs.

Ranbaxy said the products commanded “considerable equity” with doctors, and it will initially market them in India, though it did not name specific products acquired.

“The move strengthens Ranbaxy’s domestic presence and market share in dermatology, a high-growth therapeutic segment for the company,” Ranbaxy chairman and CEO Malvinder Mohan Singh said. “I believe the Indian pharmaceutical space is ripe for consolidation, and Ranbaxy’s intent is to accelerate this trend with a view to reach commanding positions, especially in the high-value chronic and acute therapy areas.”

This ad will auto-close in 10 seconds